Our understanding of the molecular drivers of disease has grown exponentially over the past two decades, largely due to continuous advancements in sequencing technology. DNA mutations, copy number variations, translocations, and fusions have been extensively profiled and have largely dominated the biomarker discovery field. Read our latest article published in Journal Precision Medicine to further delve into what we have learnt from RNA Research and Diagnostic Development.